Greenlight Biosciences Hldgs Pbc (GRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 3,820 | 3,023 | 1,732 | 1,768 | 257 |
| Gross Profit | 3,820 | 3,023 | 1,732 | 1,768 | 257 |
| Operating Expenses | 32,112 | 41,966 | 37,969 | 53,728 | 37,036 |
| Operating Income | -28,292 | -38,943 | -36,237 | -51,960 | -36,779 |
| Interest Expense | 1,007 | 643 | 1,069 | 1,338 | 1,073 |
| Other Income | 830 | 822 | 240 | 1,372 | -355 |
| Pre-tax Income | -28,469 | -38,764 | -37,066 | -51,926 | -38,207 |
| Income Tax | N/A | N/A | 1,092 | N/A | N/A |
| Net Income Continuous | -28,469 | -38,764 | -38,158 | -51,926 | -38,207 |
| Net Income | $-28,469 | $-38,764 | $-38,158 | $-51,926 | $-38,207 |
| EPS Basic Total Ops | -0.19 | -0.24 | -0.27 | -0.42 | -0.34 |
| EPS Basic Continuous Ops | -0.19 | -0.23 | -0.27 | -0.42 | -0.34 |
| EPS Diluted Total Ops | -0.19 | -0.24 | -0.27 | -0.42 | -0.34 |
| EPS Diluted Continuous Ops | -0.19 | -0.23 | -0.27 | -0.42 | -0.34 |
| EPS Diluted Before Non-Recurring Items | -0.19 | -0.26 | -0.27 | -0.42 | N/A |
| EBITDA(a) | $-25,958 | $-37,445 | $-34,202 | $-49,513 | $-34,683 |